US Department Penalizes 3 Airlines With $2.5M In Fines For Slow COVID-19 Refunds
The U.S. Transportation Department has fined Lufthansa, KLM, and South African Airways $2.5 million for significant delays in issuing COVID-19-related refunds.
GameStop: Is Keith “Roaring Kitty” Gill About To Become A Billionaire This Week?
Roaring Kitty Returns
Ferguson’s Q3 Margins Expand Despite Continued Deflation – Details Here
Ferguson Plc reports Q3 net sales increase but faces modest price deflation. The company said its fiscal 2024 financial guidance reflects continued volume growth and resilient gross margin despite the impact of continuing mild deflation expected for the remainder of the fiscal year.
Why Is Specialty Retailer Designer Brands’ Stock Plunging Today?
Designer Brands shares fell after disappointing Q1 FY24 earnings. Despite a 0.6% sales growth to $746.596 million, EPS of $0.080 missed estimates. Comparable sales dropped 2.5%, and the Operating income plunged 52.2% to $9.4 million.
Capricor Therapeutics Reports 3-Year Efficacy Results From HOPE-2 Open Label Extension Study Of CAP-1002 In DMD
--Results in Performance of the Upper Limb (PUL 2.0) Continue to Show Benefits in Skeletal Muscle Function After 3 Years of CAP-1002 Treatment (p< 0.001)-- --Stabilization in Left Ventricular Ejection Fraction
Bath & Body Works Clings To Q1 Profit Growth Amid Shaky International Sales: Details
Bath & Body Works exceeded analyst expectations with a Q1 FY24 sales of $1.38 billion, up from the estimated $1.36 billion. The company saw a gross profit increase of 1.7% Y/Y to $606 million, with a margin of 43.8%. Adjusted EPS was $0.38, beating the forecast of $0.32. The retailer holds $855 million in cash and equivalents as of May 4, 2024.
Dr Pepper Overtakes Pepsi To Become America’s Second Favorite Soda Behind Coca-Cola
Dr Pepper, with its unique blend of 23 flavors, has been capitalizing on the "swicy" trend.
Cyclacel’s Fadraciclib Reports Efficacy In Patient-Derived Colorectal Cancer Models At The 2024 ASCO Annual Meeting
- Novel CDK2/9 inhibitor fadraciclib induces anaphase catastrophe, a novel cancer-specific mechanism of action -BERKELEY HEIGHTS, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc.
Citi Trends Down After Q1 Results – Here’s Why
Citi Trends' Q1 results, featuring mixed earnings and a lowered FY24 outlook, prompt drop in premarket trading.
Equillium Announces Topline Data From Phase 2 Study Of EQ101 In Alopecia Areata; 20% Of All Subjects That Completed The 24-week Treatment Period Achieved SALT ≤ 20; EQ101 Was Well Tolerated In Subjects With Alopecia Areata With No Serious Adverse Event…
20% of all subjects that completed the 24-week treatment period achieved SALT ≤ 2029% of completed subjects with moderate to severe disease (baseline SALT 35 to <95) achieved SALT ≤ 20EQ101 was well tolerated in